• Register Your Study
  •  Login
  • Home
  • EQ-5D
  • EuroQol Group
  • News
  • Contact
  • Home
  • EQ-5D
  • EQ-5D products
  • What is EQ-5D?
  • EQ-5D products
    • EQ-5D-3L translations
    • EQ-5D-5L translations
    • EQ-5D-Y translations
    • Translation process
  • How to obtain EQ-5D
  • Valuation of EQ-5D
  • Population norms
  • Proceedings search
  • Reference search
  • Publications
  • FAQs

EQ-5D products

 

 

 

 

EQ-5D-3L

The EQ-5D-3L (EQ-5D 3 level) is available in more than 150 translated versions.

Although the EQ-5D-3L was primarily designed for self-completion in paper format by the patient or respondent, EQ-5D data can also be collected using the following alternative modes of administration:
-----------------------------------------------------------------------------------------

  •    Proxy paper
  •    Web

       

                

  •    Face to face
  •    Tablet
  •    Telephone
  •    PDA
  •    IVR

-----------------------------------------------------------------------------------------

Available 3L translations »   I   Alternative modes of administration »

 

 

EQ-5D-5L

The EuroQol Group launched a new EQ-5D-5L (EQ-5D 5 level) self complete version in 2009 with the aim of further improving the sensitivity and reducing ceiling effects of the existing EQ-5D-3L version. This is now available in paper and tablet format. Future plans include EQ-5D-5L versions in web format.
-----------------------------------------------------------------------------------------
Available 5L translations »   I   Alternative modes of administration »

 

 

 



EQ-5D-Y

The EQ-5D-Y (EQ-5D Youth version) is an EQ-5D-3L self complete version for children and adolescents aged 7-12 years. It is available in 9 languages.
-----------------------------------------------------------------------------------------
Available Y translations »   I   Recent publications »

 

 

EQ-5D bolt-ons/dimension extensions

Bolt-ons (add-ons/dimension extensions) identify key dimensions of HRQol which may be important to patients but are not captured by the EQ-5D. Until now, they have not been part of the EQ research agenda but the EuroQol Executive Committee has approved the development of a systematic, scientifically robust approach to the development of EQ-5D bolt-on dimensions for use in different clinical areas.

 

CONTACT US | DISCLAIMER | SITEMAP

Copyright Notice
All content ©  EuroQol Group | TYPO3 door Redkiwi